BioSig Technologies (NASDAQ:BSGM – Get Free Report) is expected to be posting its quarterly earnings results before the market opens on Monday, May 19th. Analysts expect BioSig Technologies to post earnings of ($0.18) per share for the quarter.
BioSig Technologies Trading Up 2.4%
BSGM stock opened at $2.61 on Friday. BioSig Technologies has a fifty-two week low of $0.20 and a fifty-two week high of $3.08. The business’s 50 day moving average price is $0.95 and its two-hundred day moving average price is $1.18.
Analysts Set New Price Targets
Separately, Ascendiant Capital Markets cut their price target on BioSig Technologies from $2.75 to $2.50 and set a “buy” rating on the stock in a research note on Monday, April 21st.
BioSig Technologies Company Profile
BioSig Technologies, Inc, together with its subsidiaries, a medical device company, engages in development and commercialization of advanced digital signal processing technology platform for the treatment of cardiovascular arrhythmias in the United States. It offers PURE EP system, a signal processing platform that combines hardware and software to address known challenges associated to signal acquisition that enables electrophysiologists to see signals and analyze in real-time, as well as is designed to address long-standing limitations that slow and disrupt cardiac catheter ablation procedures.
Featured Articles
- Five stocks we like better than BioSig Technologies
- How to Calculate Inflation Rate
- Meta’s 5 Key Pillars for AI Growth—Zuckerberg’s Bold Vision
- What is MarketRank™? How to Use it
- Retail Investors Are Betting Big on Rocket Lab—Should You Too?
- How to Buy Cheap Stocks Step by Step
- GE Aerospace: Qatar Deal Fuels Multi-Billion Dollar Growth Engine
Receive News & Ratings for BioSig Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioSig Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
